Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis

Recruiting now

Conditions studied: Systemic Sclerosis (SSc), Scleroderma

In brief

The aim of this study was to investigate respiratory muscle sarcopenia in individuals with systemic sclerosis. The main question it aims to answer is: What is the prevalence of respiratory muscle sarcopenia in patients with systemic sclerosis? Participants body composition (bioelectrical impedance), hand grip strength (hand dynanometer), physical performance tests (5 repetition sit-and-stand test, 4-meter walk test, Timed up-and-go test) and respiratory muscle strength were evaluated.

Key facts

Study ID

NCT06598982

Run by

Selcuk University

People needed

85

Starts

2024-07-01

Expected to finish

2025-07-01

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Being between the ages of 18-75
• 2013 To be diagnosed with systemic sclerosis according to ACR/EULAR classification criteria
• Being clinically stable
• Ability to adapt to tests (visual, cognitive, cooperative)

You may not qualify if…

• Those with neurological and/or musculoskeletal problems that may affect the work
• Presence of severe joint contracture or painful ulcers that may affect muscle strength measurement and walking
• Presence of severe infection or sepsis
• Being diagnosed with a known additional rheumatologic disease
• Any stage of cancer
• Pregnant or breastfeeding

Where it is running

• Selcuk University — Konya, Selcuklu, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.